小児臨床試験市場レポート：2023-2033
Paediatric Clinical Trials Market Report 2023-2033
レポート詳細
小児臨床試験市場レポート 2023-2033 :本レポートは、新たな収益源の開拓を目指すリーディングカンパニーにとって、業界とその基礎となる力学をより深く理解する上で、非常に貴重なもの... もっと見る
※上記価格は部署ライセンス（Departmental licence）価格です。
その他の価格についてはデータリソースまでお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。
サマリー
レポート詳細
小児臨床試験市場レポート 2023-2033:本レポートは、新たな収益源の開拓を目指すリーディングカンパニーにとって、業界とその基礎となる力学をより深く理解する上で、非常に貴重なものとなるでしょう。また、異業種への進出や新地域での既存事業の拡大を目指す企業にとっても有益なレポートです。
臨床試験に関する高コストが業界成長の妨げになる可能性が高い
小児科の臨床試験は、成人の臨床試験と比較して、患者1人当たりの費用が2～5倍かかるという調査結果があります。隠れたコストと患者の募集は、小児臨床試験の状況に影響を与える主要な要因です。さらに、小児が関与するインフォームド・コンセントのプロセスは、コストとともにユニークで複雑な課題を追加します。血液検査、尿検査、わずかな食事の変更、わずかな心理テストなどの研究に参加する場合、片方の保護者のみの同意で十分です。しかし、試験の重大さや複雑さによっては、保護者の同意と同時に子どもの同意が必要になることがあります。小児科医の同意が必要な場合、書類の追加、修正、募集と維持のための試験の遅れ、試験センターへの訪問時間の長さなどにより、追加費用が発生する。これらの要因により、小児臨床試験の実施に高いコスト負担が発生し、市場の成長に影響を与える可能性があります。
マーケットリサーチレポートを購入する前に、どのような質問をするべきか？
- 小児臨床試験市場はどのように進化しているのか？
- 小児臨床試験市場を牽引し、抑制しているものは何か？
- 小児臨床試験サブマーケットの各セグメントは予測期間中にどのように成長し、2033年にこれらのサブマーケットが占める売上はどの程度になるのか？
- 2023年から2033年にかけて、小児臨床試験の各サブマーケットの市場シェアはどのように推移するのでしょうか？
- 2023年から2033年にかけて、市場全体の主な牽引役となるのは何か？
- 小児臨床試験の主要市場はマクロ経済ダイナミクスに概ね追随するのか、それとも個々の国別市場が他を凌駕するのか？
- 2033年までに各国市場のシェアはどのように変化し、2033年に市場をリードするのはどの地域か？
- 主要プレイヤーは誰で、予測期間中の見通しはどうなっているのか？
- これらの主要企業の小児臨床試験プロジェクトはどのようなものか？
- 2023年から2033年の間に、業界はどのように進化していくのでしょうか？現在および今後10年間に実施される小児臨床試験プロジェクトはどのような意味を持つのか？
- 小児臨床試験市場をさらに拡大するために、製品の商業化の必要性は高まっているのか？
- 小児臨床試験市場はどこに向かっているのか、そして市場の最前線に立つためにはどうすればよいのか？
- 新製品やサービスラインへの最適な投資方法は何か？
- 企業を新たな成長軌道に乗せ、C-suiteに移行させるための重要な展望は何か？
このことが、現在、そして今後10年間の小児臨床試験市場にどのような影響を与えるかを知る必要があります：
- 230ページにわたる本レポートでは、118の表、165のチャート、グラフを独占的に提供します。
- 本レポートでは、業界における主要な収益性の高い分野を取り上げているため、今すぐその分野をターゲットにすることができます。
- 世界、地域、国の売上と成長を詳細に分析しています。
- 競合他社が成功した主要なトレンド、変化、収益予測をハイライトしています。
本レポートは、小児臨床試験市場が今後10年間にどのように発展するか、またCOVID-19の景気後退やバウンスの変化に合わせて、今日あなたに伝えます。この市場は、過去10年間のどの時点よりも今が重要なのです。
2033年までの予測やその他の分析により、商業的な展望を明らかにする。
- 今回の調査では、2033年までの収益予測に加え、直近の実績、成長率、市場シェアも掲載しています。
- ビジネスの展望や展開など、独自の分析がご覧いただけます。
- 質的な分析（市場力学、促進要因、機会、阻害要因、課題など）、コスト構造、小児臨床試験価格上昇の影響、最近の動向などをご覧いただけます。
本レポートでは、COVID-19が業界や貴社にどのような影響を与えるかについて、データ分析および貴重な知見を提供しています。COVID-19の4つの回収パターン、すなわち「V」「L」「W」「U」の回収パターンとその影響について考察しています。
報告書の対象セグメント
適応症
- 感染症領域
- 腫瘍学
- 自己免疫疾患・炎症性疾患
- 呼吸器疾患
- 精神疾患
- その他の適応症
フェーズ
- フェーズ1
- フェーズ2
- フェーズ3
- フェーズ4
試験デザイン
- 介入研究
- 観察研究
世界市場全体およびセグメントの収益予測に加え、5つの地域および21の主要国市場の収益予測も掲載しています：
北米
- アメリカ
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- その他の欧州地域
アジア太平洋地域
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他のアジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他のラテンアメリカ地域
MEA
- GCC
- 南アフリカ
- その他のMEA地域
小児臨床試験市場の2023年から2033年にかけての主要企業のプロファイルと、これらの企業のこのセグメントに焦点を当てたいくつかの企業についても報告しています。
主要企業と市場成長の可能性
・ BMS
・ Charles River Laboratories
・ GSK
・ ICON plc
・ IQVIA Inc.
・ LabCorp Drug Development
・ Novartis
・ Pfizer Inc.
・ PPD Inc.
・ Premier Research
・ QPS Holdings
・ Syneos Health
・ The Emmes Company, LLC
小児臨床試験市場の世界全体の売上高、2023年から2033年までの金額ベースで、2023年に212億5370万米ドルを突破すると当研究所は算出しました。2033年まで収益が大きく伸びることが予測されます。当社の調査では、最も大きな可能性を秘めた企業を特定しています。彼らの能力、進歩、商業的な展望を発見し、あなたが一歩先を行くのを支援します。
小児臨床試験市場、2023年から2033年までのレポートはどのように役立つのでしょうか？
要約すると、230ページにわたるレポートでは、以下のような知識を得ることができます：
- 小児臨床試験市場の2023年から2033年までの収益予測。適応症、フェーズ、試験デザイン別に予測し、それぞれ世界と地域レベルで予測 - 業界の展望を発見し、投資や収益に最も有利な場所を見つけることができます。
- 5つの地域と16の主要国市場の2033年までの収益予測 - 小児臨床試験市場の2023年から2033年の市場予測を北米、欧州、アジア太平洋、中南米、MEAでご覧いただけます。また、米国、カナダ、メキシコ、ブラジル、ドイツ、フランス、英国、イタリア、中国、インド、日本、オーストラリアなど、著名な経済圏の市場も予測されています。
- 小児臨床試験市場に参入する主要企業13社の企業プロファイルを含む、2023年から2033年までの市場展望。
独自の予測による定量・定性分析をご覧いただけます。私たちのレポートだけが持つ情報を入手し、貴重なビジネスインテリジェンスとして情報を得ることができます。
他にはない情報
私たちの新しいレポートがあれば、知識に遅れをとったり、チャンスを逃したりする可能性は低くなります。私たちの仕事があなたの研究、分析、意思決定にどのように役立つかをご覧ください。Visiongainの研究は、小児臨床試験市場、2023年から2033年、市場をリードする企業のための商業分析を必要とするすべての人のためのものです。データ、トレンド、予測をご覧いただけます。
ページTOPに戻る
目次
目次
1 レポートの概要
1.1 研究の目的
1.2 小児臨床試験市場の紹介
1.3 本レポートが提供するもの
1.4 本レポートを読むべき理由
1.5 本分析レポートが回答する主な質問は以下の通りです：
1.6 本レポートは誰のためのものか？
1.7 方法論
1.7.1 市場の定義
1.7.2 市場評価・予測手法
1.7.3 データの検証
1.7.3.1 プライマリーリサーチ
1.7.3.2 セカンダリーリサーチ
1.8 よくある質問(FAQ)
1.9 関連するVisiongainのレポート
1.10 Visiongainについて
2 エグゼクティブサマリー
3 市場の概要
3.1 主要な調査結果
3.2 マーケットダイナミクス
3.2.1 市場牽引要因
3.2.1.1 発展途上国への注目の高まり
3.2.1.2 子供の病気に対する高い有病率
3.2.2 市場抑制要因
3.2.2.1 臨床研究に関連する高いコストが市場の成長を抑制している
3.2.3 市場機会
3.2.3.1 小児科研究への投資の増加
3.3 COVID-19影響度分析
3.4 ポーターのファイブフォース分析
3.4.1 サプライヤーパワー
3.4.2 バイヤーパワー
3.4.3 競争力のあるライバル
3.4.4 代替品からの脅威
3.4.5 新規参入の脅威
4 小児臨床試験市場分析：適応症別
4.1 主要な調査結果
4.2 適応症別セグメント 市場魅力度指数
4.3 適応症別の小児臨床試験市場規模の推定と予測
4.4 感染症領域
4.4.1 2023-2033年の地域別市場規模（US$ Mn)
4.4.2 地域別市場シェア、2023年＆2033年(%)
4.5 オンコロジー
4.5.1 2023-2033年の地域別市場規模（US$ Mn)
4.5.2 地域別市場シェア、2023年＆2033年(%)
4.6 自己免疫疾患／炎症性疾患
4.6.1 2023-2033年の地域別市場規模（US$ Mn)
4.6.2 地域別市場シェア、2023年＆2033年(%)
4.7 呼吸器疾患
4.7.1 2023-2033年の地域別市場規模（US$ Mn)
4.7.2 地域別市場シェア、2023年＆2033年(%)
4.8 メンタルヘルス疾患
4.8.1 2023-2033年、地域別市場規模（US$ Mn)
4.8.2 地域別市場シェア、2023年＆2033年(%)
4.9 その他の適応症
4.9.1 2023-2033年の地域別市場規模（US$ Mn)
4.9.2 その他の適応症の地域別市場規模、2023年・2033年 (%)
5 小児臨床試験市場分析：フェーズ別
5.1 主要な調査結果
5.2 フェーズセグメント市場魅力度指数
5.3 フェーズ別小児臨床試験市場規模推定と予測
5.4 小児臨床試験のフェーズ別市場シェア、2023年＆2033年
5.5 フェーズ1
5.5.1 2023-2033年の地域別市場規模（US$ Mn)
5.5.2 地域別市場シェア、2023年＆2033年(%)
5.6 フェーズ2
5.6.1 2023-2033年の地域別市場規模（US$ Mn)
5.6.2 地域別市場シェア、2023年＆2033年(%)
5.7 フェーズ3
5.7.1 2023-2033年の地域別市場規模（US$ Mn)
5.7.2 地域別市場シェア、2023年＆2033年（%）
5.8 フェーズ4
5.8.1 2023-2033年の地域別市場規模（US$ Mn)
5.8.2 地域別市場シェア、2023年＆2033年(%)
6 小児臨床試験市場分析：スタディデザイン別
6.1 主要な調査結果
6.2 スタディデザイン別セグメント 市場魅力度指数
6.3 スタディデザイン別小児臨床試験市場シェア、2023年・2033年
6.4 介入研究
6.4.1 2023-2033年の地域別市場規模（US$ Mn)
6.5 観察的研究
6.5.1 2023-2033年の地域別市場規模（US$ Mn)
7 小児臨床試験市場分析：地域別
7.1 主要な調査結果
7.2 地域別市場規模の推定と予測
8 北米の小児臨床試験市場分析
8.1 主要な調査結果
8.2 北米の小児臨床試験市場魅力度指数
8.3 北米の小児臨床試験市場規模：国別、2023年、2028年、2033年（US$ Mn)
出典：Visiongain社、2023年
8.4 北米の小児臨床試験市場規模の国別推定と予測
8.5 北米の小児臨床試験市場規模の適応症別推定と予測
8.6 北米の小児臨床試験市場規模のフェーズ別推定と予測
8.7 米国の小児臨床試験市場の分析
8.7.1 米国の小児臨床試験市場：適応症別
8.8 カナダの小児臨床試験市場の分析
8.8.1 カナダの小児臨床試験市場：適応症別
9 欧州の小児臨床試験市場分析
9.1 主要な調査結果
9.2 欧州の小児臨床試験市場魅力度指数
9.3 欧州の小児臨床試験市場規模：国別、2023-2033年（US$ Mn)
9.4 欧州の小児臨床試験市場規模の国別推定と予測
9.5 欧州の小児臨床試験市場規模の適応症別推定と予測
9.6 欧州の小児臨床試験市場規模のフェーズ別推定と予測
9.7 ドイツの小児臨床試験市場の分析
9.7.1 ドイツの小児臨床試験市場：適応症別
9.8 イギリスの小児臨床試験市場の分析
9.8.1 イギリスの小児臨床試験市場：適応症別
9.9 フランスの小児臨床試験市場の分析
9.9.1 フランスの小児臨床試験市場：適応症別
9.10 イタリアの小児臨床試験市場の分析
9.10.1 イタリアの小児臨床試験市場：適応症別
9.11 スペイン小児臨床試験市場の分析
9.11.1 スペインの小児臨床試験市場：適応症別
9.12 その他の欧州の小児臨床試験市場の分析
9.12.1 その他の欧州の小児臨床試験市場：適応症別
10 アジア太平洋地域の小児臨床試験市場分析
10.1 主要な調査結果
10.2 アジア太平洋地域の小児臨床試験市場魅力度指数
10.3 アジア太平洋地域の小児臨床試験市場の国別市場規模、2023年、2028年、2033年（US$ Mn)
10.4 アジア太平洋地域の小児臨床試験市場の国別市場規模推定と予測
10.5 アジア太平洋地域の小児臨床試験市場の適応症別市場規模推定と予測
10.6 アジア太平洋地域の小児臨床試験の市場規模フェーズ別予測と予測
10.7 日本の小児用臨床試験市場の分析
10.7.1 日本の小児臨床試験市場：適応症別
10.8 中国の小児臨床試験の市場分析
10.8.1 中国の小児臨床試験市場：適応症別
10.9 インドの小児科臨床試験市場の分析
10.9.1 インドの小児科臨床試験市場：適応症別
10.10 韓国の小児科臨床試験市場の分析
10.10.1 適応症別韓国小児臨床試験市場
10.11 オーストラリアの小児科臨床試験市場の分析
10.11.1 オーストラリアの小児科臨床試験市場：適応症別
10.12 その他のアジア太平洋地域の小児科臨床試験市場の分析
10.12.1 アジア太平洋地域の小児科臨床試験市場：適応症別
11 ラテンアメリカの小児科臨床試験市場分析
11 ラテンアメリカの小児臨床試験市場分析
11.1 主要な調査結果
11.2 ラテンアメリカの小児臨床試験市場魅力度指数
11.3 ラテンアメリカの小児臨床試験国別市場規模推定と予測
11.4 ラテンアメリカの小児臨床試験適応症別市場規模推移の推定と予測
11.5 ラテンアメリカの小児臨床試験フェーズ別市場規模推定と予測
11.6 ブラジル小児臨床試験市場分析
11.6.1 ブラジル小児臨床試験市場：適応症別
11.7 メキシコの小児臨床試験市場の分析
11.7.1 メキシコの小児臨床試験市場：適応症別
11.8 ラテンアメリカの残りの地域小児臨床試験市場の分析
11.8.1 その他のラテンアメリカ地域適応症別小児臨床試験市場
12 MEAの小児臨床試験市場分析
12.1 主要な調査結果
12.2 MEAの小児臨床試験市場魅力度指数
12.3 MEAの小児臨床試験市場の国別推移、2023年、2028年＆2033年（US$ Mn)
12.4 MEAの小児臨床試験市場規模予測・国別予測
12.5 MEAの小児臨床試験フェーズ別市場規模推移の推定と予測
12.6 南アフリカの小児科臨床試験市場の分析
12.6.1 南アフリカの小児用臨床試験市場：適応症別
12.7 GCCの小児科臨床試験の市場分析
12.7.1 GCCの小児用臨床試験市場：適応症別
12.8 その他のMEAの小児科臨床試験の市場分析
12.8.1 その他のMEA小児科臨床試験市場：適応症別
13 会社概要
13.1 Pfizer
13.1.1 企業スナップショット
13.1.2 会社概要
13.1.3 財務分析
13.1.3.1 純収益、2019-2022年
13.1.3.2 地域別市場シェア、2022年
13.1.3.3 R＆D、2019-2022年
13.1.4 製品ベンチマーキング
13.1.5 戦略的な展望
13.2 GSK
13.2.1 企業スナップショット
13.2.2 会社概要
13.2.3 財務分析
13.2.3.1 純収益、2019年～2022年
13.2.3.2 地域別市場シェア、2022年
13.2.3.3 R＆D、2019-2022年
13.2.4 製品ベンチマーキング
13.2.5 戦略的な展望
13.3 BMS
13.3.1 企業スナップショット
13.3.2 会社概要
13.3.3 財務分析
13.3.3.1 純収益、2019-2022年
13.3.3.2 地域別市場シェア、2022年
13.3.3.3 R＆D、2019年～2022年
13.3.4 製品ベンチマーキング
13.3.5 戦略的な展望
13.4 Novartis
13.4.1 企業スナップショット
13.4.2 会社概要
13.4.3 財務分析
13.4.3.1 純収益、2019年〜2022年
13.4.3.2 地域別市場シェア、2022年
13.4.3.3 R＆D、2019年～2022年
13.4.4 製品ベンチマーキング
13.4.5 戦略的な展望
13.5 Charles River
13.5.1 企業スナップショット
13.5.2 会社概要
13.5.3 財務分析
13.5.3.1 純収益、2019年〜2022年
13.5.3.2 地域別市場シェア、2022年
13.6 LabCorp Drug Development
13.6.1 カンパニースナップショット
13.6.2 会社概要
13.6.3 財務分析
13.6.3.1 純収益、2019年〜2022年
13.6.3.2 地域別市場占有率、2022年
13.6.4 製品ベンチマーキング
13.7 ICON plc
13.7.1 企業スナップショット
13.7.2 会社概要
13.7.3 財務分析
13.7.3.1 純収益、2019年〜2022年
13.7.3.2 地域別市場シェア、2022年
13.8 IQVIA Inc.
13.8.1 企業スナップショット
13.8.2 会社概要
13.8.3 財務分析
13.8.3.1 純収益、2019年〜2022年
13.8.3.2 地域別市場占有率、2022年
13.8.4 製品ベンチマーキング
13.9 PPD Inc.
13.9.1 企業スナップショット
13.9.2 会社概要
13.9.3 財務分析
13.9.3.1 純収益、2019年〜2022年
13.9.3.2 地域別市場シェア、2022年
13.9.3.3 R＆D、2019年～2022年
13.9.4 製品のベンチマーキング
13.10 シネオス・ヘルス
13.10.1 企業スナップショット
13.10.2 会社概要
13.10.3 財務分析
13.10.3.1 純収益、2019年〜2022年
13.10.3.2 地域別市場シェア、2022年
13.10.4 製品ベンチマーキング
13.10.5 戦略的な展望
13.11 プレミアリサーチ
13.11.1 企業スナップショット
13.11.2 会社概要
13.11.3 製品ベンチマーキング
13.11.4 戦略的な展望
13.12 QPSホールディングス
13.12.1 カンパニースナップショット
13.12.2 会社概要
13.12.3 戦略的な展望
13.13 ザ・エメス・カンパニー・エルエルシー
13.13.1 カンパニー・スナップショット
13.13.2 会社概要
13.13.3 製品のベンチマーキング
14 結論と提言
14.1 ビジョンゲインからの結びの言葉
14.2 市場関係者への提言
ページTOPに戻る
図表リスト
表の一覧
Table 1 Paediatric Clinical Trials Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (V-shaped Recovery)
Table 3 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (U-shaped Recovery)
Table 4 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (W-shaped Recovery)
Table 5 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (L-shaped Recovery)
Table 6 Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 7 Pipeline of Paediatric Clinical Trials
Table 8 Infectious Disease Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 9 Pipeline of Paediatric Clinical Trials
Table 10 Oncology Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 11 Pipeline of Paediatric Clinical Trials
Table 12 Autoimmune/Inflammatory Diseases Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 13 Pipeline of Paediatric Clinical Trials
Table 14 Respiratory Disorders Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 15 Pipeline of Paediatric Clinical Trials
Table 16 Mental Health Disorders Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 17 Pipeline of Paediatric Clinical Trials
Table 18 Other Indications Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 19 Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 20 Pipeline: Paediatric Clinical Trials in Phase 1
Table 21 Phase 1 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 22 Pipeline: Paediatric Clinical Trials in Phase 2
Table 23 Phase 2 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 24 Pipeline: Paediatric Clinical Trials in Phase 3
Table 25 Phase 3 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 26 Pipeline: Paediatric Clinical Trials in Phase 4
Table 27 Phase 4 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 28 Interventional Studies Segment Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 29 Observational Studies Segment Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 30 Paediatric Clinical Trials Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 31 North America Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 32 North America Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 33 North America Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 34 US Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 35 US Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 36 Canada Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 37 Canada Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 38 Europe Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 39 Paediatric Clinical Trials Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 40 Europe Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 41 Europe Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 42 Germany Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 43 Germany Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 44 UK Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 45 UK Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 46 France Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 47 France Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 48 Italy Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 49 Italy Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 50 Spain Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 51 Spain Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 52 Rest of Europe Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 53 Rest of Europe Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 54 Asia Pacific Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 55 Asia Pacific Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 56 Asia Pacific Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 57 Asia-Pacific Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 58 Japan Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 59 Japan Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 60 China Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 61 China Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 62 India Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 63 India Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 64 South Korea Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 65 South Korea Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 66 Australia Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 67 Australia Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 68 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 69 Rest of Asia Pacific Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 70 Latin America Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 71 Latin America Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 72 Latin America Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 73 Brazil Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 74 Brazil Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 75 Mexico Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 76 Mexico Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 77 Rest of Latin America Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 78 Rest of LATAM Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 79 MEA Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 80 MEA Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 81 South Africa Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 82 South Africa Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 83 GCC Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 84 GCC Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 85 Rest of MEA Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 86 Rest of MEA Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 87 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Pfizer: Product Benchmarking
Table 89 Pfizer Inc: Company Recent Developments
Table 90 GSK: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 GSK: Product Benchmarking
Table 92 GSK: Company Recent Developments
Table 93 BMS: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 BMS: Product Benchmarking
Table 95 BMS: Company Recent Developments
Table 96 Novartis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Novartis: Product Benchmarking
Table 98 Novartis: Company Recent Developments
Table 99 Charles River: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 LabCorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 LabCorp Drug Development: Product Benchmarking
Table 102 ICON: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 IQVIA Inc.: Product Benchmarking
Table 105 PPD Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 PPD Inc.: Product Benchmarking
Table 107 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Syneos Health: Product Benchmarking
Table 109 Syneos Health: Company Recent Developments
Table 110 Premier Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Premier Research: Product Benchmarking
Table 112 Premier Research: Company Recent Developments
Table 113 QPS Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 QPS Holdings: Company Recent Developments
Table 115 Emmes: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Emmes: Product Benchmarking
図の一覧
Figure 1 Paediatric Clinical Trials Market Segmentation
Figure 2 Paediatric Clinical Trials Market by Indication: Market Attractiveness Index
Figure 3 Paediatric Clinical Trials Market by Phase: Market Attractiveness Index
Figure 4 Paediatric Clinical Trials Market: Market Dynamics
Figure 5 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 6 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 7 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 8 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 9 Paediatric Clinical Trials Market: Porter’s Five Forces Analysis
Figure 10 Paediatric Clinical Trials Market by Indication: Market Attractiveness Index
Figure 11 Paediatric Clinical Trials Market Share Forecast by Indication, 2023 and 2033 (%)
Figure 12 Paediatric Clinical Trials Market Forecast by Indication, 2023 & 2033 (%)
Figure 13 Infectious diseases Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 14 Infectious diseases Market Share by Region, 2023 & 2033 (%)
Figure 15 Oncology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 16 Oncology Market Share by Region, 2023 & 2033 (%)
Figure 17 Autoimmune/Inflammatory Diseases Market Forecast by Region, 2023-2033 (US$ Million)
Figure 18 Autoimmune/Inflammatory Diseases Market Share Forecast by Region, 2023-2033 (%)
Figure 19 Respiratory Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 20 Respiratory Disorders Market Share Forecast by Region, 2023-2033 (%)
Figure 21 Mental Health Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 22 Mental Health Disorders Market Share by Region, 2023 & 2033 (%)
Figure 23 Other Disease Market Forecast by Region, 2023-2033 (US$ Million)
Figure 24 Other Disease Market Share by Region, 2023 & 2033 (%)
Figure 25 Paediatric Clinical Trials Market by Phase: Market Attractiveness Index
Figure 26 Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 27 Paediatric Clinical Trials Market Share Forecast by Phase, 2023, 2033 (%)
Figure 28 Phase 1 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Phase 1 Market Share by Region, 2023 & 2033 (%)
Figure 30 Phase 2 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Phase 2 Market Share by Region, 2023 & 2033 (%)
Figure 32 Phase 3 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Phase 3 Market Share by Region, 2023 & 2033 (%)
Figure 34 Phase 4 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 Phase 4 Market Share by Region, 2023 & 2033 (%)
Figure 36 Paediatric Clinical Trials Market by Study design: Market Attractive Index
Figure 37 Paediatric Clinical Trials Market Share Forecast by Study design, 2023, 2033 (%)
Figure 38 Paediatric Clinical Trials Market Forecast by Interventional studies, 2023-2033 (US$ Million, AGR %)
Figure 39 Paediatric Clinical Trials Market Forecast by Observational studies, 2023-2033 (US$ Million, AGR %)
Figure 40 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 41 Paediatric Clinical Trials Market Share Forecast by Region 2023 and 2033(%)
Figure 42 Paediatric Clinical Trials Market Forecast by Region 2023 and 2033 (Revenue)
Figure 43 North America Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 44 North America Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ million, AGR%)
Figure 45 North America Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 47 North America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 48 North America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 49 North America Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 50 North America Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 51 U.S. Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 52 U.S. Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 53 U.S. Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 54 Canada Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 55 Canada Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 56 Canada Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 57 Europe Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 58 Europe Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million)
Figure 59 Europe Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 60 Europe Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 61 Europe Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 62 Europe Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 63 Europe Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 64 Europe Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 65 Germany Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 66 Germany Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 67 Germany Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 68 UK Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 U.K. Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 70 U.K. Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 71 France Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 France Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 73 France Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 74 Italy Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Italy Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 76 Italy Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 77 Spain Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 78 Spain Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 79 Spain Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 80 Rest of Europe Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 81 Rest of Europe Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 82 Rest of Europe Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 83 Asia Pacific Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 84 Asia Pacific Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 85 Asia Pacific Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 86 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 Asia Pacific Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 88 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 89 Asia Pacific Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 90 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 91 Japan Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Japan Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 93 Japan Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 94 China Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 95 China Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 96 China Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 97 India Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 India Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 99 India Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 100 South Korea Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 South Korea Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 102 South Korea Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 103 Australia Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Australia Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 105 Australia Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 106 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Asia Pacific Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 109 Latin America Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 110 Latin America Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 111 Latin America Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 112 Latin America Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Latin America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 115 Latin America Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 116 Latin America Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 117 Brazil Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 Brazil Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 119 Brazil Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 120 Mexico Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 Mexico Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 122 Mexico Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 123 Rest of Latin America Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 Rest of Latin America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 125 Rest of Latin America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 126 MEA Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 127 MEA Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 128 MEA Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 129 MEA Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 130 MEA Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 131 MEA Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 132 South Africa Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 133 South Africa Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 134 South Africa Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 135 GCC Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 136 GCC Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 137 GCC Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 138 Rest of MEA Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 Rest of MEA Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 140 Rest of MEA Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 141 Pfizer: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 142 Pfizer: Regional Market Shares, 2022
Figure 143 Pfizer: R&D, 2019-2022 (US$ million, AGR%)
Figure 144 GSK: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 145 GSK: Regional Market Shares, 2022
Figure 146 GSK: R&D, 2019-2022 (US$ million, AGR%)
Figure 147 BMS: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 148 BMS: Regional Market Shares, 2022
Figure 149 BMS: R&D, 2019-2022 (US$ million, AGR%)
Figure 150 Novartis: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 151 Novartis: Regional Market Shares, 2022
Figure 152 Novartis: R&D, 2019-2022 (US$ million, AGR%)
Figure 153 Charles River: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 154 Charles River: Regional Market Shares, 2022
Figure 155 LabCorp Drug Development: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 156 LabCorp Drug Development: Regional Market Shares, 2022
Figure 157 ICON plc: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 158 ICON plc: Regional Market Shares, 2022
Figure 159 IQVIA Inc.: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 160 IQVIA Inc.: Regional Market Shares, 2022
Figure 161 PPD Inc.: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 162 PPD Inc.: Regional Market Shares, 2022
Figure 163 PPD Inc.: R&D, 2019-2022 (US$ million, AGR%)
Figure 164 Syneos Health: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 165 Syneos Health: Regional Market Shares, 2022
ページTOPに戻る
Summary
Report Details
The Paediatric Clinical Trials Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
High Costs Related to Clinical Studies Likely to Hamper Industry Growth
As per studies, paediatric clinical trials cost 2 to 5 times higher per patient compared to clinical trials conducted in adults. Hidden costs and patient recruitment are major factors impacting the paediatric clinical trial landscape. In addition, informed consent process involving children further adds unique and complex challenges along with costs. Consent of only one parent/guardian is adequate for a child’s participation in studies such as blood tests, urinalysis, slight dietary alterations, and few psychological tests. However, depending on the severity and complexity of the trial the child’s consent may be required along with parental consent. Paediatric consent then results in additional costs due to additional documentation, need for amendments, study delays due to recruitment and retention, and longer visits to the study centres. These factors lead to high-cost burden in conducting paediatric clinical trials that may impact the growth of the market.
What Questions Should You Ask before Buying a Market Research Report?
• How is the paediatric clinical trials market evolving?
• What is driving and restraining the paediatric clinical trials market?
• How will each Paediatric clinical trials submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each Paediatric clinical trials submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading Paediatric clinical trials markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the Paediatric clinical trials projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of Paediatric clinical trials projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the paediatric clinical trials market?
• Where is the paediatric clinical trials market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Paediatric Clinical Trials Market today, and over the next 10 years:
• Our 230-page report provides 118 tables, 165 charts, and graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Paediatric Clinical Trials Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Paediatric clinical trials prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Indication
• Infectious Disease
• Oncology
• Autoimmune/Inflammatory Diseases
• Respiratory Disorders
• Mental Health Disorders
• Other Indications
Phase
• Phase 1
• Phase 2
• Phase 3
• Phase 4
Study Design
• Interventional Studies
• Observational Studies
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
The report also includes profiles and for some of the leading companies in the Paediatric clinical trials Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• BMS
• Charles River Laboratories
• GSK
• ICON plc
• IQVIA Inc.
• LabCorp Drug Development
• Novartis
• Pfizer Inc.
• PPD Inc.
• Premier Research
• QPS Holdings
• Syneos Health
• The Emmes Company, LLC
Overall world revenue for Paediatric clinical trials Market, 2023 to 2033 in terms of value the market will surpass US$21,253.7 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Paediatric clinical trials Market, 2023 to 2033 report help you?
In summary, our 230-page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Paediatric clinical trials Market, 2023 to 2033 Market, with forecasts for indication, phase, and study design, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 16 key national markets – See forecasts for the Paediatric clinical trials Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 13 of the major companies involved in the Paediatric clinical trials Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Paediatric clinical trials Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
ページTOPに戻る
Table of Contents
Table of Contents
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Paediatric Clinical Trials Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Increased Focus on Developing Economies
3.2.1.2 High Prevalence of Diseases Among Children
3.2.2 Market Restraining Factors
3.2.2.1 High Costs Related to Clinical Studies are Restraining Growth of the Market
3.2.3 Market Opportunities
3.2.3.1 Rise in Investments for Paediatric Research
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Supplier Power
3.4.2 Buyer Power
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
4 Paediatric Clinical Trials Market Analysis by Indication
4.1 Key Findings
4.2 Indication Segment: Market Attractiveness Index
4.3 Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
4.4 Infectious Diseases
4.4.1 Market Size by Region, 2023-2033 (US$ Mn)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Oncology
4.5.1 Market Size by Region, 2023-2033 (US$ Mn)
4.5.2 Market Share by Region, 2023 & 2033 (%)
4.6 Autoimmune/Inflammatory Diseases
4.6.1 Market Size by Region, 2023-2033 (US$ Mn)
4.6.2 Market Share by Region, 2023 & 2033 (%)
4.7 Respiratory Disorders
4.7.1 Market Size by Region, 2023-2033 (US$ Mn)
4.7.2 Market Share by Region, 2023 & 2033 (%)
4.8 Mental Health Disorders
4.8.1 Market Size by Region, 2023-2033 (US$ Mn)
4.8.2 Market Share by Region, 2023 & 2033 (%)
4.9 Other Indications
4.9.1 Market Size by Region, 2023-2033 (US$ Mn)
4.9.2 Other Disease Market Share by Region, 2023 & 2033 (%)
5 Paediatric Clinical Trials Market Analysis by Phase
5.1 Key Findings
5.2 Phase Segment: Market Attractiveness Index
5.3 Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
5.4 Paediatric Clinical Trials Market Share by Phase, 2023 & 2033
5.5 Phase 1
5.5.1 Market Size by Region, 2023-2033 (US$ Mn)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Phase 2
5.6.1 Market Size by Region, 2023-2033 (US$ Mn)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Phase 3
5.7.1 Market Size by Region, 2023-2033 (US$ Mn)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Phase 4
5.8.1 Market Size by Region, 2023-2033 (US$ Mn)
5.8.2 Market Share by Region, 2023 & 2033 (%)
6 Paediatric Clinical Trials Market Analysis by Study design
6.1 Key Findings
6.2 Study design Segment: Market Attractiveness Index
6.3 Paediatric Clinical Trials Market Share by Study design, 2023 & 2033
6.4 Interventional Studies
6.4.1 Market Size Estimation, 2023-2033 (US$ Mn)
6.5 Observational studies
6.5.1 Market Size Estimation, 2023-2033 (US$ Mn)
7 Paediatric Clinical Trials Market Analysis by Region
7.1 Key Findings
7.2 Regional Market Size Estimation and Forecast
8 North America Paediatric Clinical Trials Market Analysis
8.1 Key Findings
8.2 North America Paediatric Clinical Trials Market Attractiveness Index
8.3 North America Paediatric Clinical Trials Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
Source: Visiongain, 2023
8.4 North America Paediatric Clinical Trials Market Size Estimation and Forecast by Country
8.5 North America Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
8.6 North America Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
8.7 U.S. Paediatric Clinical Trials Market Analysis
8.7.1 U.S. Paediatric Clinical Trials Market by Indication
8.8 Canada Paediatric Clinical Trials Market Analysis
8.8.1 Canada Paediatric Clinical Trials Market by Indication
9 Europe Paediatric Clinical Trials Market Analysis
9.1 Key Findings
9.2 Europe Paediatric Clinical Trials Market Attractiveness Index
9.3 Europe Paediatric Clinical Trials Market Size by Country, 2023-2033 (US$ Mn)
9.4 Europe Paediatric Clinical Trials Market Size Estimation and Forecast by Country
9.5 Europe Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
9.6 Europe Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
9.7 Germany Paediatric Clinical Trials Market Analysis
9.7.1 Germany Paediatric Clinical Trials Market by Indication
9.8 U.K. Paediatric Clinical Trials Market Analysis
9.8.1 U.K. Paediatric Clinical Trials Market by Indication
9.9 France Paediatric Clinical Trials Market Analysis
9.9.1 France Paediatric Clinical Trials Market by Indication
9.10 Italy Paediatric Clinical Trials Market Analysis
9.10.1 Italy Paediatric Clinical Trials Market by Indication
9.11 Spain Paediatric Clinical Trials Market Analysis
9.11.1 Spain Paediatric Clinical Trials Market by Indication
9.12 Rest of Europe Paediatric Clinical Trials Market Analysis
9.12.1 Rest of Europe Paediatric Clinical Trials Market by Indication
10 Asia Pacific Paediatric Clinical Trials Market Analysis
10.1 Key Findings
10.2 Asia Pacific Paediatric Clinical Trials Market Attractiveness Index
10.3 Asia Pacific Paediatric Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Asia Pacific Paediatric Clinical Trials Market Size Estimation and Forecast by Country
10.5 Asia Pacific Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
10.6 Asia Pacific Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
10.7 Japan Paediatric Clinical Trials Market Analysis
10.7.1 Japan Paediatric Clinical Trials Market by Indication
10.8 China Paediatric Clinical Trials Market Analysis
10.8.1 China Paediatric Clinical Trials Market by Indication
10.9 India Paediatric Clinical Trials Market Analysis
10.9.1 India Paediatric Clinical Trials Market by Indication
10.10 South Korea Paediatric Clinical Trials Market Analysis
10.10.1 South Korea Paediatric Clinical Trials Market by Indication
10.11 Australia Paediatric Clinical Trials Market Analysis
10.11.1 Australia Paediatric Clinical Trials Market by Indication
10.12 Rest of Asia Pacific Paediatric Clinical Trials Market Analysis
10.12.1 Rest of Asia Pacific Paediatric Clinical Trials Market by Indication
11 Latin America Paediatric Clinical Trials Market Analysis
11.1 Key Findings
11.2 Latin America Paediatric Clinical Trials Market Attractiveness Index
11.3 Latin America Paediatric Clinical Trials Market Size Estimation and Forecast by Country
11.4 Latin America Paediatric Clinical Trials Market Size Estimation and Forecast by Indication
11.5 Latin America Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
11.6 Brazil Paediatric Clinical Trials Market Analysis
11.6.1 Brazil Paediatric Clinical Trials Market by Indication
11.7 Mexico Paediatric Clinical Trials Market Analysis
11.7.1 Mexico Paediatric Clinical Trials Market by Indication
11.8 Rest of Latin America Paediatric Clinical Trials Market Analysis
11.8.1 Rest of Latin America Paediatric Clinical Trials Market by Indication
12 MEA Paediatric Clinical Trials Market Analysis
12.1 Key Findings
12.2 MEA Paediatric Clinical Trials Market Attractiveness Index
12.3 MEA Paediatric Clinical Trials Market by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 MEA Paediatric Clinical Trials Market Size Estimation and Forecast by Country
12.5 MEA Paediatric Clinical Trials Market Size Estimation and Forecast by Phase
12.6 South Africa Paediatric Clinical Trials Market Analysis
12.6.1 South Africa Paediatric Clinical Trials Market by Indication
12.7 GCC Paediatric Clinical Trials Market Analysis
12.7.1 GCC Paediatric Clinical Trials Market by Indication
12.8 Rest of MEA Paediatric Clinical Trials Market Analysis
12.8.1 Rest of MEA Paediatric Clinical Trials Market by Indication
13 Company Profiles
13.1 Pfizer
13.1.1 Company Snapshot
13.1.2 Company Overview
13.1.3 Financial Analysis
13.1.3.1 Net Revenue, 2019-2022
13.1.3.2 Regional Market Shares, 2022
13.1.3.3 R&D, 2019-2022
13.1.4 Product Benchmarking
13.1.5 Strategic Outlook
13.2 GSK
13.2.1 Company Snapshot
13.2.2 Company Overview
13.2.3 Financial Analysis
13.2.3.1 Net Revenue, 2019-2022
13.2.3.2 Regional Market Shares, 2022
13.2.3.3 R&D, 2019-2022
13.2.4 Product Benchmarking
13.2.5 Strategic Outlook
13.3 BMS
13.3.1 Company Snapshot
13.3.2 Company Overview
13.3.3 Financial Analysis
13.3.3.1 Net Revenue, 2019-2022
13.3.3.2 Regional Market Shares, 2022
13.3.3.3 R&D, 2019-2022
13.3.4 Product Benchmarking
13.3.5 Strategic Outlook
13.4 Novartis
13.4.1 Company Snapshot
13.4.2 Company Overview
13.4.3 Financial Analysis
13.4.3.1 Net Revenue, 2019-2022
13.4.3.2 Regional Market Shares, 2022
13.4.3.3 R&D, 2019-2022
13.4.4 Product Benchmarking
13.4.5 Strategic Outlook
13.5 Charles River
13.5.1 Company Snapshot
13.5.2 Company Overview
13.5.3 Financial Analysis
13.5.3.1 Net Revenue, 2019-2022
13.5.3.2 Regional Market Shares, 2022
13.6 LabCorp Drug Development
13.6.1 Company Snapshot
13.6.2 Company Overview
13.6.3 Financial Analysis
13.6.3.1 Net Revenue, 2019-2022
13.6.3.2 Regional Market Shares, 2022
13.6.4 Product Benchmarking
13.7 ICON plc
13.7.1 Company Snapshot
13.7.2 Company Overview
13.7.3 Financial Analysis
13.7.3.1 Net Revenue, 2019-2022
13.7.3.2 Regional Market Shares, 2022
13.8 IQVIA Inc.
13.8.1 Company Snapshot
13.8.2 Company Overview
13.8.3 Financial Analysis
13.8.3.1 Net Revenue, 2019-2022
13.8.3.2 Regional Market Shares, 2022
13.8.4 Product Benchmarking
13.9 PPD Inc.
13.9.1 Company Snapshot
13.9.2 Company Overview
13.9.3 Financial Analysis
13.9.3.1 Net Revenue, 2019-2022
13.9.3.2 Regional Market Shares, 2022
13.9.3.3 R&D, 2019-2022
13.9.4 Product Benchmarking
13.10 Syneos Health
13.10.1 Company Snapshot
13.10.2 Company Overview
13.10.3 Financial Analysis
13.10.3.1 Net Revenue, 2019-2022
13.10.3.2 Regional Market Shares, 2022
13.10.4 Product Benchmarking
13.10.5 Strategic Outlook
13.11 Premier Research
13.11.1 Company Snapshot
13.11.2 Company Overview
13.11.3 Product Benchmarking
13.11.4 Strategic Outlook
13.12 QPS Holdings
13.12.1 Company Snapshot
13.12.2 Company Overview
13.12.3 Strategic Outlook
13.13 The Emmes Company, LLC
13.13.1 Company Snapshot
13.13.2 Company Overview
13.13.3 Product Benchmarking
14 Conclusion and Recommendations
14.1 Concluding Remarks from Visiongain
14.2 Recommendations for Market Players
ページTOPに戻る
List of Tables/Graphs
List of Tables
Table 1 Paediatric Clinical Trials Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (V-shaped Recovery)
Table 3 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (U-shaped Recovery)
Table 4 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (W-shaped Recovery)
Table 5 Paediatric Clinical Trials Market Forecast, by Region, 2023-2033 (US$ Mn, AGR %, CAGR %) (L-shaped Recovery)
Table 6 Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 7 Pipeline of Paediatric Clinical Trials
Table 8 Infectious Disease Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 9 Pipeline of Paediatric Clinical Trials
Table 10 Oncology Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 11 Pipeline of Paediatric Clinical Trials
Table 12 Autoimmune/Inflammatory Diseases Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 13 Pipeline of Paediatric Clinical Trials
Table 14 Respiratory Disorders Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 15 Pipeline of Paediatric Clinical Trials
Table 16 Mental Health Disorders Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 17 Pipeline of Paediatric Clinical Trials
Table 18 Other Indications Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 19 Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 20 Pipeline: Paediatric Clinical Trials in Phase 1
Table 21 Phase 1 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 22 Pipeline: Paediatric Clinical Trials in Phase 2
Table 23 Phase 2 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 24 Pipeline: Paediatric Clinical Trials in Phase 3
Table 25 Phase 3 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 26 Pipeline: Paediatric Clinical Trials in Phase 4
Table 27 Phase 4 Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 28 Interventional Studies Segment Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 29 Observational Studies Segment Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 30 Paediatric Clinical Trials Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 31 North America Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 32 North America Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 33 North America Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 34 US Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 35 US Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 36 Canada Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 37 Canada Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 38 Europe Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 39 Paediatric Clinical Trials Segment Market Forecast, by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 40 Europe Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 41 Europe Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 42 Germany Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 43 Germany Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 44 UK Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 45 UK Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 46 France Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 47 France Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 48 Italy Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 49 Italy Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 50 Spain Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 51 Spain Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 52 Rest of Europe Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 53 Rest of Europe Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 54 Asia Pacific Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 55 Asia Pacific Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 56 Asia Pacific Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 57 Asia-Pacific Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 58 Japan Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 59 Japan Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 60 China Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 61 China Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 62 India Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 63 India Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 64 South Korea Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 65 South Korea Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 66 Australia Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 67 Australia Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 68 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 69 Rest of Asia Pacific Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 70 Latin America Paediatric Clinical Trials Market, By Country, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 71 Latin America Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 72 Latin America Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 73 Brazil Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 74 Brazil Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 75 Mexico Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 76 Mexico Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 77 Rest of Latin America Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 78 Rest of LATAM Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 79 MEA Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 80 MEA Paediatric Clinical Trial Phase Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 81 South Africa Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 82 South Africa Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 83 GCC Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 84 GCC Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 85 Rest of MEA Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 86 Rest of MEA Paediatric Clinical Trial Indication Market Forecast, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Table 87 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Pfizer: Product Benchmarking
Table 89 Pfizer Inc: Company Recent Developments
Table 90 GSK: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 GSK: Product Benchmarking
Table 92 GSK: Company Recent Developments
Table 93 BMS: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 94 BMS: Product Benchmarking
Table 95 BMS: Company Recent Developments
Table 96 Novartis: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 97 Novartis: Product Benchmarking
Table 98 Novartis: Company Recent Developments
Table 99 Charles River: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 100 LabCorp Drug Development: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 LabCorp Drug Development: Product Benchmarking
Table 102 ICON: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 103 IQVIA Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 IQVIA Inc.: Product Benchmarking
Table 105 PPD Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 106 PPD Inc.: Product Benchmarking
Table 107 Syneos Health: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 108 Syneos Health: Product Benchmarking
Table 109 Syneos Health: Company Recent Developments
Table 110 Premier Research: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 111 Premier Research: Product Benchmarking
Table 112 Premier Research: Company Recent Developments
Table 113 QPS Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 QPS Holdings: Company Recent Developments
Table 115 Emmes: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Emmes: Product Benchmarking
List of Figures
Figure 1 Paediatric Clinical Trials Market Segmentation
Figure 2 Paediatric Clinical Trials Market by Indication: Market Attractiveness Index
Figure 3 Paediatric Clinical Trials Market by Phase: Market Attractiveness Index
Figure 4 Paediatric Clinical Trials Market: Market Dynamics
Figure 5 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 6 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 7 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 8 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 9 Paediatric Clinical Trials Market: Porter’s Five Forces Analysis
Figure 10 Paediatric Clinical Trials Market by Indication: Market Attractiveness Index
Figure 11 Paediatric Clinical Trials Market Share Forecast by Indication, 2023 and 2033 (%)
Figure 12 Paediatric Clinical Trials Market Forecast by Indication, 2023 & 2033 (%)
Figure 13 Infectious diseases Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 14 Infectious diseases Market Share by Region, 2023 & 2033 (%)
Figure 15 Oncology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 16 Oncology Market Share by Region, 2023 & 2033 (%)
Figure 17 Autoimmune/Inflammatory Diseases Market Forecast by Region, 2023-2033 (US$ Million)
Figure 18 Autoimmune/Inflammatory Diseases Market Share Forecast by Region, 2023-2033 (%)
Figure 19 Respiratory Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 20 Respiratory Disorders Market Share Forecast by Region, 2023-2033 (%)
Figure 21 Mental Health Disorders Market Forecast by Region, 2023-2033 (US$ Million)
Figure 22 Mental Health Disorders Market Share by Region, 2023 & 2033 (%)
Figure 23 Other Disease Market Forecast by Region, 2023-2033 (US$ Million)
Figure 24 Other Disease Market Share by Region, 2023 & 2033 (%)
Figure 25 Paediatric Clinical Trials Market by Phase: Market Attractiveness Index
Figure 26 Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 27 Paediatric Clinical Trials Market Share Forecast by Phase, 2023, 2033 (%)
Figure 28 Phase 1 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Phase 1 Market Share by Region, 2023 & 2033 (%)
Figure 30 Phase 2 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Phase 2 Market Share by Region, 2023 & 2033 (%)
Figure 32 Phase 3 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Phase 3 Market Share by Region, 2023 & 2033 (%)
Figure 34 Phase 4 Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 Phase 4 Market Share by Region, 2023 & 2033 (%)
Figure 36 Paediatric Clinical Trials Market by Study design: Market Attractive Index
Figure 37 Paediatric Clinical Trials Market Share Forecast by Study design, 2023, 2033 (%)
Figure 38 Paediatric Clinical Trials Market Forecast by Interventional studies, 2023-2033 (US$ Million, AGR %)
Figure 39 Paediatric Clinical Trials Market Forecast by Observational studies, 2023-2033 (US$ Million, AGR %)
Figure 40 Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 41 Paediatric Clinical Trials Market Share Forecast by Region 2023 and 2033(%)
Figure 42 Paediatric Clinical Trials Market Forecast by Region 2023 and 2033 (Revenue)
Figure 43 North America Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 44 North America Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ million, AGR%)
Figure 45 North America Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 46 North America Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 47 North America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 48 North America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 49 North America Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 50 North America Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 51 U.S. Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 52 U.S. Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 53 U.S. Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 54 Canada Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 55 Canada Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 56 Canada Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 57 Europe Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 58 Europe Paediatric Clinical Trials Market Forecast by Region, 2023-2033 (US$ Million)
Figure 59 Europe Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 60 Europe Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 61 Europe Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 62 Europe Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 63 Europe Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 64 Europe Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 65 Germany Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 66 Germany Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 67 Germany Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 68 UK Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 69 U.K. Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 70 U.K. Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 71 France Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 72 France Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 73 France Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 74 Italy Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 75 Italy Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 76 Italy Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 77 Spain Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 78 Spain Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 79 Spain Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 80 Rest of Europe Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 81 Rest of Europe Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 82 Rest of Europe Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 83 Asia Pacific Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 84 Asia Pacific Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 85 Asia Pacific Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 86 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 Asia Pacific Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 88 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 89 Asia Pacific Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 90 Asia Pacific Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 91 Japan Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 92 Japan Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 93 Japan Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 94 China Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 95 China Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 96 China Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 97 India Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 India Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 99 India Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 100 South Korea Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 South Korea Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 102 South Korea Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 103 Australia Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 Australia Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 105 Australia Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 106 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Rest of Asia Pacific Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Asia Pacific Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 109 Latin America Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 110 Latin America Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 111 Latin America Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 112 Latin America Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Latin America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 114 Latin America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 115 Latin America Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 116 Latin America Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 117 Brazil Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 118 Brazil Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 119 Brazil Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 120 Mexico Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 121 Mexico Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 122 Mexico Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 123 Rest of Latin America Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 Rest of Latin America Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 125 Rest of Latin America Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 126 MEA Paediatric Clinical Trials Market by Country: Market Attractiveness Index
Figure 127 MEA Paediatric Clinical Trials Market Forecast by Region, 2023, 2028 & 2033 (US$ Million)
Figure 128 MEA Paediatric Clinical Trials Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
Figure 129 MEA Paediatric Clinical Trials Market Share Forecast by Country, 2023 & 2033 (%)
Figure 130 MEA Paediatric Clinical Trials Market Forecast by Phase, 2023-2033 (US$ Million, AGR %)
Figure 131 MEA Paediatric Clinical Trials Market Share Forecast by Phase, 2023 & 2033 (%)
Figure 132 South Africa Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 133 South Africa Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 134 South Africa Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 135 GCC Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 136 GCC Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 137 GCC Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 138 Rest of MEA Paediatric Clinical Trials Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 139 Rest of MEA Paediatric Clinical Trials Market Forecast by Indication, 2023-2033 (US$ Million, AGR %)
Figure 140 Rest of MEA Paediatric Clinical Trials Market Share Forecast by Indication, 2023 & 2033 (%)
Figure 141 Pfizer: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 142 Pfizer: Regional Market Shares, 2022
Figure 143 Pfizer: R&D, 2019-2022 (US$ million, AGR%)
Figure 144 GSK: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 145 GSK: Regional Market Shares, 2022
Figure 146 GSK: R&D, 2019-2022 (US$ million, AGR%)
Figure 147 BMS: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 148 BMS: Regional Market Shares, 2022
Figure 149 BMS: R&D, 2019-2022 (US$ million, AGR%)
Figure 150 Novartis: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 151 Novartis: Regional Market Shares, 2022
Figure 152 Novartis: R&D, 2019-2022 (US$ million, AGR%)
Figure 153 Charles River: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 154 Charles River: Regional Market Shares, 2022
Figure 155 LabCorp Drug Development: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 156 LabCorp Drug Development: Regional Market Shares, 2022
Figure 157 ICON plc: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 158 ICON plc: Regional Market Shares, 2022
Figure 159 IQVIA Inc.: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 160 IQVIA Inc.: Regional Market Shares, 2022
Figure 161 PPD Inc.: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 162 PPD Inc.: Regional Market Shares, 2022
Figure 163 PPD Inc.: R&D, 2019-2022 (US$ million, AGR%)
Figure 164 Syneos Health: Net Revenue, 2019-2022 (US$ million, AGR%)
Figure 165 Syneos Health: Regional Market Shares, 2022
ページTOPに戻る
本レポートと同分野（医療/ヘルスケア）の最新刊レポート
Visiongain社の医薬・化学品分野での最新刊レポート
本レポートと同じKEY WORD（clinical trials）の最新刊レポート
よくあるご質問
Visiongain社はどのような調査会社ですか?
英国の調査会社ヴィジョンゲイン社（Visiongain）は、通信とエネルギーのほか、自動車や化学・医薬品、金属など、広範な市場を対象に調査を行っています。自動車市場については、市場全般に関する調査のほ... もっと見る
調査レポートの納品までの日数はどの程度ですか?
在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。
注文の手続きはどのようになっていますか?
1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。
お支払方法の方法はどのようになっていますか?
納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。
データリソース社はどのような会社ですか?
当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。
|
|
